Physician profile
Vikram J Deka
NPI 1306040498
$154,320.73
in general payments reported to CMS, 2019-2025
7 companies · $3,658 in 2025
The $3,658 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $42K · 2021: $21K · 2022: $4,574 · 2023: $17K · 2024: $17K · 2025: $3,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Education: $8,300 · Food and Beverage: $5,345 · Travel and Lodging: $5,273 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,500.00 |
| Education | $8,300.00 |
| Food and Beverage | $5,345.04 |
| Travel and Lodging | $5,272.85 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $109,052.62 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $24,385.24 | 2021-2025 | Progrip, Absorbatack, Dextile |
| Covidien LP | $20,160.73 | 2019-2020 | |
| Davol INC. | $444.59 | 2023-2025 | Phasix Mesh |
| Tela Bio, INC. | $142.73 | 2024 | Ovitex 2s |
| Ethicon US, LLC | $121.11 | 2020 | |
| Innocoll Pharmaceuticals Limited | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Deka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.